Coronavirus Could Be the Final Nail in the Coffin for Bombardier’s (TSX:BBD.B) Stock

With coronavirus ravaging global travel, Bombardier Inc (TSX:BBD.B) may be finished.

| More on:
You Should Know This

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more

Bombardier Inc (TSX:BBD.B) stock has been having a rough go of it lately. As of this writing, it had fallen 45% since February 19–compared to 34% for the TSX. With the extreme coronavirus response measures that have been rolled out recently, it’s understandable that stocks would take a beating. Bombardier, however, has been battered more than most.

While it’s normal to talk about buying the dip in times like this, that’s probably not the best approach to Bombardier stock. As you’re about to see, the ongoing coronavirus panic could legitimately threaten the company’s operations.

With business travel taking a beating due to travel restrictions, Bombardier could lose orders and suffer major revenue declines. To understand why that would be so devastating to the business, we first need to look at its history.

A business in decline

Most Canadians will be familiar with Bombardier’s recent woes. Its massive layoffs and business unit spinoffs have been well publicized, as have its balance sheet struggles. However, Bombardier’s issues go back further than most people realize.

A quick glance at Bombardier’s stock chart shows that it peaked in September 2000 at a price of about $27. Shortly afterward, it began a free-fall that has continued to the present day.

The company’s first questionable asset divestiture was selling Bombardier Recreational Products to Bain Capital for $1.2 billion. The sale came as Bombardier reported a $1 billion net loss and a 15% revenue drop-off for the final quarter of 2003.

While it’s normal for businesses to sell off units, Bombardier’s sale to Bain Capital appears to have been motivated by a desire to offset staggering losses.

The sale also deprived Bombardier of a business unit that has gone on to be successful under new management: In the five years spanning 2015 to 2019, BRP grew its revenue by 10% CAGR and didn’t have a single losing year.

The loss of BRP was just the start of Bombardier’s woes. The real one-two punch came in the form of the C Series jet. Initially projected to cost $2.1 billion, it wound up costing $5.4 billion and loading up the company’s balance sheet with debt.

Bombardier also struggled to find buyers for the jet, which led to it being sold to Airbus. That was the start of a long series of asset divestures that continued until last year.

Business jets: the only business unit remaining

Having sold off recreational products, much of its aviation, and trains, business aviation is the only major business unit Bombardier has left. Unfortunately, depending on how the coronavirus threat plays out, that could be in danger too. Coronavirus is cancelling business travel left and right, with many companies opting out of non-essential travel entirely.

Just recently, Starbucks turned its annual meeting into a virtual event, and Nestle told its employees to limit business travel.

These are but two examples out of hundreds. If coronavirus remains a going concern, then we’ll almost certainly see fewer business jet orders, which won’t be good news for Bombardier’s last remaining business. For these and other reasons, investors would do well to avoid Bombardier stock.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Andrew Button has no position in any of the stocks mentioned. David Gardner owns shares of Starbucks. Tom Gardner owns shares of Starbucks. The Motley Fool owns shares of and recommends Starbucks. The Motley Fool recommends Nestle.

More on Coronavirus

little girl in pilot costume playing and dreaming of flying over the sky
Coronavirus

Air Canada Stock: How High Could it go?

AC stock is up 29% in the last six months alone, so should we expect more great things? Or is…

Read more »

eat food
Coronavirus

Goodfood Stock Doubles Within Days: Time to Buy?

Goodfood (TSX:FOOD) stock has surged 125% in the last few weeks, so what happened, and should investors hop back on…

Read more »

stock data
Tech Stocks

If I Could Only Buy 1 Stock Before 2023, This Would Be It

This stock is the one company that really doesn't deserve its ultra-low share price, so I'll definitely pick it up…

Read more »

Aircraft Mechanic checking jet engine of the airplane
Coronavirus

Air Canada Stock Fell 5% in November: Is it a Buy Today?

Air Canada (TSX:AC) stock saw remarkable improvements during its last quarter but still dropped 5% with more recession hints. So,…

Read more »

Airport and plane
Coronavirus

Is Air Canada Stock a Buy Today?

Airlines are on the rebound. Does Air Canada stock deserve to be on your buy list?

Read more »

A patient takes medicine out of a daily pill box.
Coronavirus

Retirees: 2 Healthcare Stocks That Could Help Set You up for Life

Healthcare stocks offer an incredible opportunity for growth for those investors who look to the right stocks, such as these…

Read more »

sad concerned deep in thought
Coronavirus

Here’s Why I Just Bought WELL Health Stock

WELL Health stock (TSX:WELL) may be a healthcare stock and a tech stock, but don't let that keep you from…

Read more »

healthcare pharma
Coronavirus

WELL Stock: The Safe Stock Investors Can’t Afford to Ignore

WELL stock (TSX:WELL) fell 68% from peak to trough, and yet there's no good reason as to why. So now…

Read more »